{"DataElement":{"publicId":"3461831","version":"1","preferredName":"Papillary or Follicular (Differentiated) Thyroid Cancer American Joint Committee on Cancer (AJCC) Edition 7 45 Years and Older Group Stage","preferredDefinition":"Stage group determined from information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for papillary or follicular cancer (differentiated) in cases 45 years of age or older.","longName":"3461585v1.0:3461798v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3461585","version":"1","preferredName":"Differentiated Thyroid Gland Carcinoma Greater Than or Equal To Age 45 Stage Grouping","preferredDefinition":"An adenocarcinoma arising from the thyroid gland showing extensive evidence of follicular cell differentiation.  According to the nuclear features of the malignant follicular cells, it is classified either as papillary, or follicular carcinoma. (NCI05)_A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status._How long something has existed; elapsed time since birth._A number with no fractional part, including the negative and positive numbers as well as zero.::45_An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage._A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways._How long something has existed; elapsed time since birth._A number with no fractional part, including the negative and positive numbers as well as zero.::45_An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"3461579v1.0:3461583v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3461579","version":"1","preferredName":"Differentiated Thyroid Gland Carcinoma","preferredDefinition":"An adenocarcinoma arising from the thyroid gland showing extensive evidence of follicular cell differentiation.  According to the nuclear features of the malignant follicular cells, it is classified either as papillary, or follicular carcinoma. (NCI05)","longName":"C7153","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Differentiated Thyroid Gland Carcinoma","conceptCode":"C7153","definition":"An adenocarcinoma that arises from the thyroid gland and shows extensive evidence of follicular cell differentiation.  According to the nuclear features of the malignant follicular cells, it is classified either as papillary or follicular carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C02DD092-1787-CCAB-E040-BB89AD430207","latestVersionIndicator":"Yes","beginDate":"2012-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-16","modifiedBy":"ONEDATA","dateModified":"2012-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3461583","version":"1","preferredName":"Greater Than or Equal To Age Integer::45 Stage Grouping","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.:How long something has existed; elapsed time since birth.:A number with no fractional part, including the negative and positive numbers as well as zero.::45:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"3461583v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than or Equal To","conceptCode":"C61583","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Age","conceptCode":"C25150","definition":"How long something has existed; elapsed time since birth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C02E2605-3A46-F131-E040-BB89AD434F9B","latestVersionIndicator":"Yes","beginDate":"2012-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-16","modifiedBy":"ONEDATA","dateModified":"2012-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C02E2605-3A57-F131-E040-BB89AD434F9B","latestVersionIndicator":"Yes","beginDate":"2012-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CRF standard harmonization. mc 5/16/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3461798","version":"1","preferredName":"Differentiated Thyroid Gland Carcinoma Age 45 And Over American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"An adenocarcinoma arising from the thyroid gland showing extensive evidence of follicular cell differentiation.  According to the nuclear features of the malignant follicular cells, it is classified either as papillary, or follicular carcinoma. (NCI05)_A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways._How long something has existed; elapsed time since birth._A number with no fractional part, including the negative and positive numbers as well as zero.::45_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3461798v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"13","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IVC","valueDescription":"Stage IVC Differentiated Thyroid Gland Carcinoma","ValueMeaning":{"publicId":"3461800","version":"1","preferredName":"Stage IVC Differentiated Thyroid Gland Carcinoma","longName":"3461800","preferredDefinition":"Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7","conceptCode":"C87548","definition":"Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C03DD87C-016C-38A8-E040-BB89AD4310F6","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C03DD87C-0185-38A8-E040-BB89AD4310F6","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"ONEDATA","dateModified":"2012-05-17","deletedIndicator":"No"},{"value":"IVB","valueDescription":"Stage IVB Differentiated Thyroid Gland Carcinoma","ValueMeaning":{"publicId":"3461802","version":"1","preferredName":"Stage IVB Differentiated Thyroid Gland Carcinoma","longName":"3461802","preferredDefinition":"Stage IVB includes: T4b, Any N, M0. T4b: Very advanced disease.  Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7","conceptCode":"C87547","definition":"Stage IVB includes: T4b, Any N, M0. T4b: Very advanced disease.  Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C03DD87C-0192-38A8-E040-BB89AD4310F6","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C03DD87C-01AB-38A8-E040-BB89AD4310F6","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"ONEDATA","dateModified":"2012-05-17","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Stage IVA Differentiated Thyroid Gland Carcinoma","ValueMeaning":{"publicId":"3461804","version":"1","preferredName":"Stage IVA Differentiated Thyroid Gland Carcinoma","longName":"3461804","preferredDefinition":"Stage IVA includes: (T4a, N0, M0); (T4a, N1a, M0); (T1, N1b, M0); (T2, N1b, M0); (T3, N1b, M0); (T4a, N1b, M0). T4a: Moderately advanced local disease.  Tumor of any size extending beyond the thyroid gland capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve. ).  T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland.  T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland.  T3: Tumor more than 4 cm in greatest dimension and limited to the thyroid gland, or tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues).  N0: No regional lymph node metastasis.  N1a: Metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes).  N1b: Metastasis to unilateral, bilateral or contralateral cervical (Levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (Level VII).  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7","conceptCode":"C87546","definition":"Stage IVA includes: (T4a, N0, M0); (T4a, N1a, M0); (T1, N1b, M0); (T2, N1b, M0); (T3, N1b, M0); (T4a, N1b, M0). T4a: Moderately advanced local disease.  Tumor of any size extending beyond the thyroid gland capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve.  T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland.  T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland.  T3: Tumor more than 4 cm in greatest dimension and limited to the thyroid gland, or tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues).  N0: No regional lymph node metastasis.  N1a: Metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes).  N1b: Metastasis to unilateral, bilateral or contralateral cervical (Levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (Level VII).  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C03DD87C-01B8-38A8-E040-BB89AD4310F6","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C03DD87C-01D1-38A8-E040-BB89AD4310F6","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"ONEDATA","dateModified":"2012-05-17","deletedIndicator":"No"},{"value":"III","valueDescription":"Stage III Differentiated Thyroid Gland Carcinoma","ValueMeaning":{"publicId":"3461806","version":"1","preferredName":"Stage III Differentiated Thyroid Gland Carcinoma","longName":"3461806","preferredDefinition":"Stage III includes: (T3, N0, M0); (T1, N1a, M0); (T2, N1a, M0); (T3, N1a, M0). T3: Tumor greater than 4 cm in greatest dimension and limited to the thyroid gland, or tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues).  T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland.  T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland.  N0: No regional lymph node metastasis.  N1a: Metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes).  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Differentiated Thyroid Gland Carcinoma AJCC v7","conceptCode":"C87545","definition":"Stage III includes: (T3, N0, M0); (T1, N1a, M0); (T2, N1a, M0); (T3, N1a, M0). T3: Tumor greater than 4 cm in greatest dimension and limited to the thyroid gland, or tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues).  T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland.  T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland.  N0: No regional lymph node metastasis.  N1a: Metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes).  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C03DD87C-01DE-38A8-E040-BB89AD4310F6","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C03DD87C-01F7-38A8-E040-BB89AD4310F6","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"ONEDATA","dateModified":"2012-05-17","deletedIndicator":"No"},{"value":"II","valueDescription":"Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older","ValueMeaning":{"publicId":"3461807","version":"1","preferredName":"Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older","longName":"3461807","preferredDefinition":"Stage II includes: T2, N0, M0.  T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland.  N0: No regional lymph node metastasis.  M0: No evidence of distant metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7","conceptCode":"C101542","definition":"Stage II includes: T2, N0, M0.  T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland.  N0: No regional lymph node metastasis.  M0: No evidence of distant metastasis.  (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C03DD87C-0203-38A8-E040-BB89AD4310F6","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C03DD87C-021C-38A8-E040-BB89AD4310F6","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"ONEDATA","dateModified":"2012-05-17","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older","ValueMeaning":{"publicId":"3461808","version":"1","preferredName":"Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older","longName":"3461808","preferredDefinition":"T1, N0, M0.  T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland.  N0: No regional lymph node metastasis.  M0: No evidence of distant metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7","conceptCode":"C101540","definition":"Stage I includes: T1, N0, M0.  T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland.  N0: No regional lymph node metastasis.  M0: No evidence of distant metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C03DD87C-0228-38A8-E040-BB89AD4310F6","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C03DD87C-0241-38A8-E040-BB89AD4310F6","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"ONEDATA","dateModified":"2012-05-17","deletedIndicator":"No"},{"value":"Stage unknown","valueDescription":"Stage Unknown","ValueMeaning":{"publicId":"3357508","version":"1","preferredName":"Stage Unknown","longName":"3357508","preferredDefinition":"A finding indicating that the extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Unknown","conceptCode":"C92207","definition":"The extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D76279-6263-2CA8-E040-BB89AD434A54","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C03E0DED-63A3-9912-E040-BB89AD437BF5","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"ONEDATA","dateModified":"2012-05-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3461797","version":"1","preferredName":"Differentiated Thyroid Gland Carcinoma Greater Than or Equal To Age Integer::45 American Joint Committee on Cancer Stage Grouping Stage","preferredDefinition":"An adenocarcinoma arising from the thyroid gland showing extensive evidence of follicular cell differentiation.  According to the nuclear features of the malignant follicular cells, it is classified either as papillary, or follicular carcinoma. (NCI05):A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.:How long something has existed; elapsed time since birth.:A number with no fractional part, including the negative and positive numbers as well as zero.::45:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3461797v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Differentiated Thyroid Gland Carcinoma","conceptCode":"C7153","definition":"An adenocarcinoma that arises from the thyroid gland and shows extensive evidence of follicular cell differentiation.  According to the nuclear features of the malignant follicular cells, it is classified either as papillary or follicular carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Greater Than or Equal To","conceptCode":"C61583","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Age","conceptCode":"C25150","definition":"How long something has existed; elapsed time since birth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C03DD87C-0140-38A8-E040-BB89AD4310F6","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"ONEDATA","dateModified":"2012-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C03DD87C-0151-38A8-E040-BB89AD4310F6","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"COOPERM","dateModified":"2012-05-17","changeDescription":"Created for CRF standard harmonization. mc 5/17/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3434443","version":"1","longName":"Thyroid","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000283","version":"1","longName":"Thyroid","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"Papillary of Follicular Disea","type":"Preferred Question Text","description":"Papillary of Follicular Disease Stage, 45 Years and Older","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"C03E0DED-649A-9912-E040-BB89AD437BF5","latestVersionIndicator":"Yes","beginDate":"2012-05-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-17","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization and released per community approval. mc 5/17/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}